Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07587294

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07587294
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07587294. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-15 (actual); primary completion 2027-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction
Acronym
US-PRAY
Condition
Acute ST-segment Elevation Myocardial Infarction (Patients Undergoing Emergency PCI)
Intervention (Device)
Ultrasound modulation of the left stellate ganglion
Intervention (Device)
Sham ultrasound modulation of the left stellate ganglion
Lead sponsor
Renmin Hospital of Wuhan University (class: other)
Collaborator
Wuhan Third Hospital (class: other)
Collaborator
Xiangyang Central Hospital (class: other)
Collaborator
Wuhan Central Hospital (class: other)
Collaborator
Taihe Hospital (class: other)
Collaborator
Jingzhou Central Hospital (class: other)
Collaborator
Huangshi Central Hospital (class: other)

Record details

Record id
cardio:ct-nct07587294
Content hash
967dcefd07654f37dff5b500877d89b54175c04cc874a0aa4170df03826ee19d